Revisiting alginate paradigms
Revisiting alginate paradigms
批准号:
10294953
负责人:
Daniel J Wozniak
金额:
$48.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-11-03 至 2023-10-31
关键词:
AlginatesAntimicrobial ResistanceBacteriaBiochemicalBiochemical GeneticsBiologyCellsChronicChronic lung diseaseClinicalCommunitiesCystic FibrosisDataDiseaseEquilibriumGenetic DiseasesGoalsHypersensitivityImmune responseImmunologicsInterventionKnowledgeLung infectionsMaintenanceMediatingMicrobial BiofilmsMolecularMonitorMutationPathogenesisPatientsPersonsPhenotypePolysaccharidesPopulationPrevalenceProductionPropertyProteinsPseudomonas aeruginosaPulmonary Cystic FibrosisReactive Oxygen SpeciesResearchRespiratory Tract InfectionsRoleStructureTestingTranslatingVariantVirulenceantimicrobialantimicrobial drugchronic infectionclinical prognosiscostcystic fibrosis airwaycystic fibrosis patientseffective therapyexperimental studyfitnessgenetic approachhigh riskimmunopathologyin vivoinfection riskinflammatory milieumembermicrobial communitymicrobiotamucoidnovel therapeuticsopportunistic pathogenpatient populationtrait
中文摘要
项目摘要
本申请试图通过以下方式来定义藻酸盐过量生产的分子机制和适合性益处:
铜绿假单胞菌的粘液样变体。具体来说,我们将定义藻酸盐生物膜基质的特征
这增强了铜绿假单胞菌的持久性,并更好地理解了藻酸盐在维持被动
保护CF气道中的铜绿假单胞菌微生物群落。
该提案将使用最先进的分子,生物化学,免疫学和遗传学方法来探测
藻酸盐发病机制的各个方面,并重新评估一些长期存在的范例。迄今为止,
产生藻酸盐的细菌的潜在生物膜形成还没有被很好地理解。目标1将调查
藻酸盐生物膜基质的生物化学和遗传学基础维持生物膜的完整性,结构,
抗微生物抗性特性。虽然很明显,粘液变体在慢性气道炎症中占主导地位,
在CF患者中感染时,它们很少以纯克隆粘液分离株的形式存在。相反,粘液细菌
典型地与未经历粘液样变性的野生型铜绿假单胞菌的混合群体相关,
转换,以及自发的抑制剂出现。目标2的目标是检验假设,
混合聚生体赋予铜绿假单胞菌群落作为一个整体的健身效益,这是在
非粘液或粘液细菌单独存在。CF肺中的藻酸盐表达与不良的临床表现相关,
预后然而,在我们的知识中,关于藻酸盐的特定性质,
过量生产在气道内提供细菌和微生物聚生体。这些目标的实现
将导致对藻酸盐生物学的更深入理解,并转化为CF的新疗法或干预措施
粘液型铜绿假单胞菌定植患者。
英文摘要
Project Abstract
This application seeks to define the molecular mechanisms and fitness benefits of alginate overproduction by
mucoid variants of Pseudomonas aeruginosa. Specifically we will define features of the alginate biofilm matrix
that enhance P. aeruginosa persistence and better understand the role of alginate in maintaining passive
protection to the P. aeruginosa microbial community in the CF airway.
This proposal will use state-of-the art molecular, biochemical, immunological, and genetic approaches to probe
aspects of alginate pathogenesis and to reevaluate some long-standing paradigms. To date, the mechanisms
underlying biofilm formation by alginate producing bacteria is not well understood. Aim 1 will investigate the
biochemical and genetic basis for alginate biofilm matrix maintenance of biofilm integrity, structure, and
antimicrobial resistance properties. While it is clear that mucoid variants predominate during chronic airway
infection in CF patients, rarely are they present as pure clonal mucoid isolates. Instead, mucoid bacteria are
typically associated with mixed populations of wild type P. aeruginosa that have not undergone mucoid
conversion, as well as spontaneous suppressors that arise. The goal of Aim 2 is to test the hypothesis that this
mixed consortia confers fitness benefits to the P. aeruginosa community as a whole that is not observed in
either nonmucoid or mucoid bacteria alone. Alginate expression in the CF lung correlates with a poor clinical
prognosis. However there are gaps in our knowledge regarding specific properties that alginate
overproduction affords bacteria and the microbial consortia within the airway. The completion of these aims
will lead to a deeper understanding of alginate biology and translate into novel therapies or interventions for CF
patients colonized with mucoid P. aeruginosa.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1128/spectrum.02056-22
发表时间:
2022-12-21
期刊:
MICROBIOLOGY SPECTRUM
影响因子:
3.7
作者:
[Chen, Anna, Dellos-Nolan, Sheri, Lu, Yanran, West, Jason S., Wozniak, Daniel J., Mitton-Fry, Mark J.]
通讯作者:
Mitton-Fry, Mark J.
DOI:
10.1021/acsinfecdis.0c00407
发表时间:
2020-11-13
期刊:
ACS infectious diseases
影响因子:
5.3
作者:
[Limqueco E, Passos Da Silva D, Reichhardt C, Su FY, Das D, Chen J, Srinivasan S, Convertine A, Skerrett SJ, Parsek MR, Stayton PS, Ratner DM]
通讯作者:
Ratner DM
DOI:
10.1128/mbio.01376-18
发表时间:
2018-09-25
期刊:
mBio
影响因子:
6.4
作者:
[Reichhardt C, Wong C, Passos da Silva D, Wozniak DJ, Parsek MR]
通讯作者:
Parsek MR
DOI:
10.1128/jb.00086-22
发表时间:
2022-05-17
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[]
通讯作者:
DOI:
10.1038/s42003-022-03453-2
发表时间:
2022-05-26
期刊:
Communications biology
影响因子:
5.9
作者:
[]
通讯作者:
共 21 条
The impact of bacteriophage therapy on wound infection dynamics
-
批准号:10467125
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2022
-
负责人:Daniel J Wozniak
-
依托单位:
The impact of bacteriophage therapy on wound infection dynamics
-
批准号:10560606
-
项目类别:
-
资助金额:$75.27万
-
财政年份:2022
-
负责人:Daniel J Wozniak
-
依托单位:
Revisiting alginate paradigms
-
批准号:10054154
-
项目类别:
-
资助金额:$48.81万
-
财政年份:2017
-
负责人:Daniel J Wozniak
-
依托单位:
Conserved complement binding to bacterial porins
-
批准号:8772309
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and immunity
-
批准号:8978289
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
The essential P. aeruginosa pan-genome during chronic infection
-
批准号:8623447
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
The essential P. aeruginosa pan-genome during chronic infection
-
批准号:8780593
-
项目类别:
-
资助金额:$19.27万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and immunity
-
批准号:8601164
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and immunity
-
批准号:8506656
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and immunity
-
批准号:9188512
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and immunity
-
批准号:8782464
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2013
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and persistence
-
批准号:7628356
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and persistence
-
批准号:7763554
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2008
-
负责人:Daniel J Wozniak
-
依托单位:
Pseudomonas biofilms and persistence
-
批准号:7355427
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2008
-
负责人:Daniel J Wozniak
-
依托单位:
Mid-Atlantic Microbial Pathogenesis Meeting
-
批准号:7225354
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2007
-
负责人:Daniel J Wozniak
-
依托单位:
The matrix of Pseudomonas aeruginosa biofilms
-
批准号:7070583
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2005
-
负责人:Daniel J Wozniak
-
依托单位:
The matrix of Pseudomonas aeruginosa biofilms
-
批准号:7558979
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2005
-
负责人:Daniel J Wozniak
-
依托单位:
The matrix of Pseudomonas aeruginosa biofilms
-
批准号:7364578
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2005
-
负责人:Daniel J Wozniak
-
依托单位:
The matrix of Pseudomonas aeruginosa biofilms
-
批准号:6989225
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2005
-
负责人:Daniel J Wozniak
-
依托单位:
The matrix of Pseudomonas aeruginosa biofilms
-
批准号:7185075
-
项目类别:
-
资助金额:$49.28万
-
财政年份:2005
-
负责人:Daniel J Wozniak
-
依托单位:
海外基金